Efforts to improve outcome
Preoperatively:
Induction chemotherapy prior to 5-FU chemoRT
Concurrent multi-agent 5-FU based chemoRT:
Biologic agents (cetuximab/bevacizumab)
Oxaliplatin: phase III evidence
6